share_log

Altimmune analyst ratings

Altimmune analyst ratings

Altimmune分析师评级
Benzinga Analyst Ratings ·  2022/05/18 06:41
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
05/18/2022 372.59% Piper Sandler $34 → $25 Maintains Overweight
06/30/2021 296.98% B. Riley Securities $41 → $21 Maintains Buy
06/30/2021 486.01% JMP Securities $53 → $31 Maintains Market Outperform
06/30/2021 372.59% HC Wainwright & Co. $35 → $25 Maintains Buy
06/16/2021 901.89% JMP Securities $45 → $53 Maintains Market Outperform
06/02/2021 561.63% HC Wainwright & Co. → $35 Initiates Coverage On → Buy
02/11/2021 580.53% Guggenheim → $36 Initiates Coverage On → Buy
11/24/2020 372.59% Evercore ISI Group → $25 Reinstates → Outperform
09/25/2020 486.01% B. Riley Securities → $31 Initiates Coverage On → Buy
07/31/2020 1412.29% Piper Sandler → $80 Initiates Coverage On → Overweight
07/28/2020 845.18% JMP Securities → $50 Initiates Coverage On → Market Outperform
07/19/2019 56.9% Roth Capital → $8.3 Initiates Coverage On → Buy
10/09/2017 13.42% Piper Sandler → $6 Initiates Coverage On → Overweight
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
05/18/2022 372.59% 派珀·桑德勒 $34 → $25 维护 超重
06/30/2021 296.98% B.莱利证券 $41 → $21 维护 买
06/30/2021 486.01% JMP证券 $53 → $31 维护 市场表现强于大盘
06/30/2021 372.59% HC Wainwright公司 $35 → $25 维护 买
06/16/2021 901.89% JMP证券 $45 → $53 维护 市场表现强于大盘
06/02/2021 561.63% HC Wainwright公司 → $35 开始承保 →购买
02/11/2021 580.53% 古根海姆 → $36 开始承保 →购买
11/24/2020 372.59% Evercore ISI集团 → $25 恢复 →跑赢大盘
09/25/2020 486.01% B.莱利证券 → $31 开始承保 →购买
07/31/2020 1412.29% 派珀·桑德勒 → $80 开始承保 →超重
07/28/2020 845.18% JMP证券 → $50 开始承保 →市场跑赢大盘
07/19/2019 56.9% 罗斯资本 → $8.3 开始承保 →购买
10/09/2017 13.42% 派珀·桑德勒 → $6 开始承保 →超重

Altimmune Questions & Answers

Altimmune问答

What is the target price for Altimmune (ALT)?
Altimmune(ALT)的目标价是多少？

The latest price target for Altimmune (NASDAQ: ALT) was reported by Piper Sandler on May 18, 2022. The analyst firm set a price target for $25.00 expecting ALT to rise to within 12 months (a possible 372.59% upside). 6 analyst firms have reported ratings in the last year.

派珀·桑德勒于2022年5月18日报道了Altimmune(纳斯达克：ALT)的最新目标价。这家分析公司将目标价定为25美元，预计ALT将在12个月内上涨至(可能上涨372.59%)。6家分析公司在过去一年公布了评级。

What is the most recent analyst rating for Altimmune (ALT)?
Altimmune(ALT)的最新分析师评级是多少？

The latest analyst rating for Altimmune (NASDAQ: ALT) was provided by Piper Sandler, and Altimmune maintained their overweight rating.

分析师对Altimmune(纳斯达克代码：ALT)的最新评级由Piper Sandler提供，Altimmune维持其增持评级。

When is the next analyst rating going to be posted or updated for Altimmune (ALT)?
Altimmune(ALT)的下一次分析师评级将于何时发布或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Altimmune, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Altimmune was filed on May 18, 2022 so you should expect the next rating to be made available sometime around May 18, 2023.

分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Altimmune的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Altimmune的最后一次评级是在2022年5月18日提交的，所以你应该预计下一次评级将在2023年5月18日左右的某个时候公布。

Is the Analyst Rating Altimmune (ALT) correct?
分析师对Altimmune(ALT)的评级正确吗？

While ratings are subjective and will change, the latest Altimmune (ALT) rating was a maintained with a price target of $34.00 to $25.00. The current price Altimmune (ALT) is trading at is $5.29, which is out of the analyst's predicted range.

虽然评级是主观的，并将发生变化，但最新的Altimmune(ALT)评级维持不变，目标价在34.00美元至25.00美元之间。Altimmune(ALT)目前的交易价格为5.29美元，超出了分析师的预测区间。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发